Nuveen LLC Invests $3.43 Million in AdaptHealth Corp. $AHCO

Nuveen LLC acquired a new stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 316,181 shares of the company’s stock, valued at approximately $3,427,000. Nuveen LLC owned 0.23% of AdaptHealth at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Connor Clark & Lunn Investment Management Ltd. purchased a new position in AdaptHealth during the first quarter valued at approximately $4,358,000. Charles Schwab Investment Management Inc. lifted its stake in shares of AdaptHealth by 14.3% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,301,652 shares of the company’s stock valued at $14,110,000 after buying an additional 163,272 shares in the last quarter. New Age Alpha Advisors LLC bought a new position in AdaptHealth in the 1st quarter worth $2,503,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its holdings in AdaptHealth by 25.3% in the 1st quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 15,871 shares of the company’s stock worth $172,000 after buying an additional 3,208 shares during the period. Finally, Seizert Capital Partners LLC purchased a new stake in AdaptHealth in the 1st quarter worth $334,000. 82.67% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on AHCO shares. Wall Street Zen upgraded AdaptHealth from a “hold” rating to a “buy” rating in a research report on Saturday, August 9th. Royal Bank Of Canada cut their target price on AdaptHealth from $14.00 to $13.00 and set an “outperform” rating for the company in a research report on Thursday, May 8th. Finally, Truist Financial cut their target price on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Monday, May 12th. Five equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $13.40.

AdaptHealth Stock Performance

NASDAQ:AHCO opened at $9.21 on Thursday. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.14. AdaptHealth Corp. has a 12-month low of $7.11 and a 12-month high of $11.70. The stock has a 50-day moving average price of $9.26 and a 200 day moving average price of $9.24. The stock has a market capitalization of $1.25 billion, a P/E ratio of 17.06, a P/E/G ratio of 1.03 and a beta of 1.58.

Insiders Place Their Bets

In other AdaptHealth news, Director David Solomon Williams III sold 8,200 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $9.73, for a total transaction of $79,786.00. Following the completion of the transaction, the director owned 50,045 shares in the company, valued at $486,937.85. This trade represents a 14.08% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.55% of the stock is owned by corporate insiders.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.